Example articles:

Applying treatment data 

Warner J. P. (1999). Evidence-based psychopharmacology 1. Appraising a single therapeutic trial: what is the evidence for treating early Alzheimer's disease with donepezil?. Journal of psychopharmacology (Oxford, England), 13(3), 308–312. https://doi.org/10.1177/026988119901300319

Communicating Risk

Skolbekken J. A. (1998). Communicating the risk reduction achieved by cholesterol reducing drugs. BMJ (Clinical research ed.), 316(7149), 1956–1958. https://doi.org/10.1136/bmj.316.7149.1956

Applying data from a systematic review

Warner J. P. (1999). Evidence-based psychopharmacology 2. Appraising a systematic review: is risperidone better than conventional antipsychotics in the treatment of schizophrenia?. Journal of psychopharmacology (Oxford, England), 13(4), 415–418. https://doi.org/10.1177/026988119901300413

Applying data on risk

Srihari, V. H., & Lee, T. W. (2008). Pulmonary embolism in a patient taking clozapine. BMJ (Clinical research ed.), 336(7659), 1499–1501. https://doi.org/10.1136/bmj.39545.690613.47

Perspective on EBM and QI

Glasziou, P., Ogrinc, G., & Goodman, S. (2011). Can evidence-based medicine and clinical quality improvement learn from each other?. BMJ quality & safety, 20 Suppl 1(Suppl_1), i13–i17. https://doi.org/10.1136/bmjqs.2010.046524

Review of heterogeneity in treatment effects

Kravitz, R. L., Duan, N., & Braslow, J. (2004). Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. The Milbank quarterly, 82(4), 661–687. https://doi.org/10.1111/j.0887-378X.2004.00327.x